Lintzeris, Nicholas; Ritter, Alison; Panjari, Mary; Clark, Nicolas; Kutin, Jozica; Bammer, Gabriele
Buprenorphine was registered in Australia as a maintenance and detoxification agent for the management of opioid dependence in November, 2000, and became widely available in August, 2001. This paper provides an overview of key developments in the introduction of buprenorphine treatment in Australia, with an emphasis upon the delivery of services in community-based (primary care) settings. A central study in this work was the Buprenorphine Implementation Trial (BIT), a randomized, controlled...[Show more]
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.